<DOC>
	<DOCNO>NCT01199588</DOCNO>
	<brief_summary>This study subject venous leg ulcer . The study do determine NEXAGON plus compression bandaging effective placebo plus compression bandaging .</brief_summary>
	<brief_title>A Study Investigate Efficacy , Safety Tolerability NexagonÂ® Topical Treatment Subjects With Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>1 . Diagnosis venous leg ulceration support venous duplex ultrasonography demonstrate venous reflux &gt; 0.5 second 2 . Ankle brachial index &gt; 0.80 3 . Venous Leg Ulcer ( VLU ) area great 2 cm2 less 20 cm2 4 . Compliant able tolerate high compression bandage 5 . VLU present &gt; 30 day prior study entry 6 . VLU full thickness 7 . The subject willing able give inform consent 1 . Decrease increase ulcer surface area 40 % 14 day runin period 2 . More 75 % VLU malleolus 3 . Presence nonstudy ulcer within 1.5 cm VLU 4 . A VLU show sign clinical infection cellulitis 5 . The VLU wound bed exposed bone , tendon fascia 6 . BMI &gt; 45.0 kg/m2 7 . Subject ambulatory 8 . Subjects past present disease , judge Investigator , may affect safety subject outcome study 9 . Cancerous cell VLU 10 . HbA1c &gt; 10 % 11 . Blood biochemistry &gt; 3x upper limit normal 12 . Heart failure NYHA class III IV 13 . Subjects renal replacement therapy 14 . Immunocompromized subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>VLU</keyword>
	<keyword>Venous Leg Ulcers</keyword>
	<keyword>Ulcers</keyword>
	<keyword>chronic wound</keyword>
	<keyword>wound</keyword>
	<keyword>Nexagon</keyword>
	<keyword>CoDa</keyword>
</DOC>